Life Extension
Life Extension years of history

Life Extension is a global authority on health, wellness and nutrition

as well as a provider of scientific information on anti-aging therapies. We supply only the highest quality nutritional supplements, including minerals, herbs, hormones and vitamins.

Access your account today: Login        Learn about our membership benefits

translation by SYSTRAN  
Overstock Blowout Sale - Save 60-80% On Top-Quality Products
 

Anemia-Thrombocytopenia-Leukopenia

References

Aihara, K. et al. Successful combination therapy-flunarizine, pentoxifylline, and cholestyramine-for spur cell anemia. Int. J. Hematol. 2001 Apr; 73(3): 351-5.

Andres, E. et al. Anemia caused by vitamin B12 deficiency in subjects aged over 75 years: new hypotheses. A study of 20 cases. Rev. Med. Interne 2000 Nov; 21(11): 946-54.

Anon. (Welch, K.J., N. Mock, N., O. Netrebenko, O.). Measuring hunger in the Russian Federation using the Radimer/Cornell hunger scale. Bull. World Health Org. 1998; 76(Suppl. 2): 34-7 (http://www.who.int/archives/pub/bull_76.html#Volume%2076,%20Number%202,%201998).

Baik, H.W., Russell, R.M. Vitamin B12 deficiency in the elderly. Annu. Rev. Nutr. 1999; 19: 357-77.

Bain, J. Andropause. Testosterone replacement therapy for aging men. Can. Fam. Physician 2001 Jan; 47: 91-7.

Blaise, D. et al. Cytokines and malignant hemopathies: leukemias and bone marrow graft. Rev. Prat. 1993 Mar 1; 43(5): 574-9 (in French).

Bradstock, K.F. The use of hematopoietic growth factors in the treatment of acute leukemia. Curr. Pharm. Des. 2002; 8(5): 343-55.

Caro, J.J. et al. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer 2001 Jun 15; 91(12): 2214-21.

Chan, S., Gerson, B., Subramaniam, S. The role of copper, molybdenum, selenium, and zinc in nutrition and health. Clin. Lab. Med. 1998 Dec; 18(4): 673-85.

De Caterina, R. et al. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler. Thromb. 1994 Nov; 14(11): 1829-36.

Eichbaum, F.W., Slemer, O., Zyngier, S.B. Anti-inflammatory effect of warfarin and vitamin K1. Naunyn Schmiedebergs Arch. Pharmacol. 1979 Jun 18; 307(2): 185-90.

Foldes, C. et al. Congenital dyschromia with erythrocyte, platelet and tryptophan metabolism abnormalities. J. Am. Acad. Dermatol. 1988 Oct; 19(4): 642-55.

Herrera, J. et al. Melatonin prevents oxidative stress resulting from iron and erythropoietin administration. Am. J. Kidney Dis. 2001 Apr; 37(4): 750-7.

Hong, S.H., Kadosawa, T., Mochizuki, M., Matsunaga, S., Nishimura, R., Sasaki, N. Effect of all-trans and 9-cis retinoic acid on growth and metastasis of xenotransplanted canine osteosarcoma cells in athymic mice. Am. J. Vet. Res. 2000 Oct; 61(10): 1241-4.

Keilholz, U., Gore, M.E. Biochemotherapy for advanced melanoma. Semin. Oncol. 2002a Oct; 29(5): 456-61.

Keilholz, U., Martus, P., Punt, C.J., Kruit, W., Mooser, G., Schadendorf, D., Lienard, D.,
Dummer, R., Koller, J., Voit, C., Eggermont, A.M. Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatments: second analysis of a randomised EORTC Melanoma Group trial comparing interferon-alpha2a (IFNalpha) and interleukin 2 (IL-2) with or without cisplatin. Eur. J. Cancer 2002b Jul; 38(11): 1501-11.
Kikuchi, M. et al. Five-year survival of older people with anemia: variation with hemoglobin concentration. J. Am. Geriatr. Soc. 2001 Sep; 49(9): 1226-8.

Kipper-Galperin, M. et al. Dehydroepiandrosterone selectively inhibits production of tumor necrosis factor alpha and interleukin-6 [correction of interlukin-6] in astrocytes. Int. J. Dev. Neurosci. 1999 Dec; 17(8): 765-75.

Kopcke, W., Sauerland, M.C. Meta-analysis of efficacy and tolerability data on iron protein succinylate in patients with iron deficiency anemia of different severity. Arzneimittelforschung 1995 Nov; 45(11): 1211-6.

Lahat, N., Alexander, B., Levin, D.R., Moskovitz, B. The relationship between clinical stage, natural killer activity and related immunological parameters in adenocarcinoma of the prostate. Cancer Immunol. Immunother. 1989; 28(3): 208-12.

Lissoni, P. Is there a role for melatonin in supportive care? Support. Care Cancer 2002 Mar; 10(2): 110-6.

Lissoni, P., Barni, S., Cazzaniga, M., Ardizzoia, A., Rovelli, F., Brivio, F., Tancini, G. Efficacy of the concomitant administration of the pineal hormone melatonin in cancer immunotherapy with low-dose IL-2 in patients with advanced solid tumors who had progressed on IL-2 alone. Oncology 1994 Jul-Aug; 51(4): 344-7.

Lissoni, P., Ardizzoia, A., Barni, S., Tancini, G., Muttini, M.P. Immunotherapy with subcutaneous low-dose interleukin-2 plus melatonin as salvage therapy of heavily chemotherapy-pretreated ovarian cancer. Oncol. Rep. 1996; 3(5): 947-9.

Lissoni, P., Paolorossi, F., Ardizzoia, A., Barni, S., Chilelli, M., Mancuso, M., Tancini, G., Conti, A., Maestroni, G.J. A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical state. J. Pineal Res. 1997a Aug; 23(1): 15-9.

Lissoni, P., Tancini, G., Barni, S., Paolorossi, F., Ardizzoia, A., Conti, A., Maestroni, G. Treatment of cancer chemotherapy-induced toxicity with the pineal hormone melatonin. Support Care Cancer 1997b Mar; 5(2): 126-9.

Little, D.R. Ambulatory management of common forms of anemia. Am. Fam. Physician 1999 Mar 15; 59(6): 1598-1604.

Mavligit, G.M., Calvo, D.B., III, Patt, Y.Z., Hersh, E.M. Immune restoration and/or augmentation of local xenogeneic graft versus host reaction by Cimetidine in vitro. J. Immunol. 1981 Jun; 126(6): 2272-4.

McMullin, M.F., Cuthbert, R.J. Transfusion in the management of patients with megaloblastic anaemia. Int. J. Clin. Pract. 1999 Mar; 53(2): 104-6.

Navarro, J.F. et al. Effects of pentoxifylline on the haematologic status in anemic patients with advanced renal failure. Scand. J. Urol. Nephrol. 1999 Apr; 33(2): 121-5.

Neri, B., de Leonardis, V., Gemelli, M.T., di Loro, F., Mottola, A., Ponchietti, R., Raugei, A., Cini, G. Melatonin as biological response modifier in cancer patients.
Anticancer Res. 1998 Mar-Apr; 18(2B): 1329-32.

Pertosa, G. et al. Clinical relevance of cytokine production in hemodialysis. Kidney Int. Suppl. 2000 Aug; 76: S104-S111.

Pugliese, P.T., Jordan, K., Cederberg, H., Brohult, J. Some biological actions of alkylglycerols from shark liver oil. J. Altern. Complement Med. 1998 Spring; 4(1): 87-99.

Ratajzak, M.Z. et al. In vitro studies on anemia in chronic inflammatory disease: influence of interleukin-6 on human erythropoietin. Pol. Merkuriusz Lek 1997 Jan; 2(9): 172-5.

Riecken, E.O., Rosewicz, S. Retinoids in pancreatic cancer. Ann. Oncol. 1999; 10(Suppl. 4): 197-200.
Rizvi, M.A., Shah, S.R., Raskob, G.E., George, J.N. Drug-induced thrombocytopenia. Curr. Opin. Hematol. 1999 Sep; 6(5): 349-53.

Rook, A.H., Masur, H., Lane, H.C., Frederick, W., Kasahara, T., Macher, A.M., Djeu, J.Y., Manischewitz, J.F., Jackson, L., Fauci, A.S., Quinnan, G.V., Jr. Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome. J. Clin. Invest. 1983 Jul; 72(1): 398-403.

Somos, S., Farkas, B. Immunomodulatory treatment with low-dose interferon-alpha and oral retinoic acid in lymphangioma-like Kaposi's sarcoma. Anticancer Res. 2000 Jan-Feb; 20(1B): 541-5.

Sullivan, P.S., Hanson, D.L., Chu, S.Y., Jones, J.L., Ward, J.W. Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood 1998 Jan 1; 91(1): 301-8.

Takasaki, Y., Moriuchi, Y., Tsushima, H., Ikeda, E., Koura, S., Taguchi, J., Fukushima, T., Tomonaga, M., Ikeda, S. Effectiveness of oral vitamin B12 therapy for pernicious anemia and vitamin B12 deficiency anemia. Rinsho Ketsueki 2002 Mar; 43(3): 165-9 (in Japanese).

Tur, E., Brenner, S. Classic Kaposi's sarcoma: low-dose interferon alfa treatment. Dermatology 1998; 197(1): 37-42.

Vaziri, N.D. et al. Dysregulation of melatonin metabolism in chronic renal insufficiency: role of erythropoietin-deficiency anemia. Kidney Int. 1996 Aug; 50(2): 653-6.

Wen, Q.S., Zhang, G.Z., Kong, X.T. Modulation effect of cimetidine on the production of IL-2 and interferon-gamma in patients with gastric cancer. Zhonghua Zhong Liu Za Zhi 1994 Jul; 16(4): 299-301 (in Chinese).

Wu, W.C. et.al. Blood transfusion in elderly patients with acute myocardial infarction. N. Engl. J. Med. 2001 Oct 25; 345(17): 1230-6.

Zitzmann, M., Nieschlag, E. Hormone substitution in male hypogonadism. Mol. Cell. Endocrinol. 2000 Mar 30; 161(1-2): 73-88.

How to Correct Anemia

Abbasi, A.A. et al. Gonadal function abnormalities in sickle cell anemia. Studies in adult male patients. Ann. Intern. Med. 1976 Nov; 85(5): 601-5.

Brinch, L. et al. Folic acid deficiency can cause severe anemia and pancytopenia. Tidsskr. Nor. Laegeforen. 1990 May 30; 110(14): 1830-1.

Bron, D. et al. Biological basis of anemia. Semin. Oncol. 2001 Apr; 28(2, Suppl. 8): 1-6.

Calder, P.C. n-3 Polyunsaturated fatty acids and cytokine production in health and disease. Ann. Nutr. Metab. 1997; 41(4): 203-34.

Calder, P.C. et al. Polyunsaturated fatty acids and rheumatoid arthritis. Curr. Opin. Clin. Nutr. Metab. Care 2001 Mar; 4(2): 115-21.

Eckardt, K.U. Anemia in critical illness. Wien Klin. Wochenschr. 2001 Feb 15; 113(3-4): 84-9.

Gao, R.L. et al. Clinical study of 63 patients with aplastic anemia by using in vitro culture of BFU-E, CFU-E, CFU-GM and of the relation between pathogenesis and treatment. Zhonghua Nei Ke Za Zhi 1991 May; 30(5): 268-72, 316.

Heslop, H.E., Bianchi, A.C., Cordingley, F.T., Turner, M., Chandima, W., De Mel, C.P., Hoffbrand, A.V., Brenner, M.K. Effects of interferon alpha on autocrine growth factor loops in B lymphoproliferative disorders. J. Exp. Med. 1990 Dec 1; 172(6): 1729-34.

James, M.J. et al. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am. J. Clin. Nutr. 2000 Jan; 71(1, Suppl.): 343S-348S.

Kelley, D.S. et al. Docosahexaenoic acid ingestion inhibits natural killer cell activity and production of inflammatory mediators in young healthy men. Lipids 1999 Apr; 34(4): 317-24.

Khalfoun, B. et al. Docosahexaenoic and eicosapentaenoic acids inhibit human lymphoproliferative responses in vitro but not the expression of T cell surface activation markers. Scand. J. Immunol. 1996 Mar; 43(3): 248-56.

Klingelhoefer, S. et al. Antirheumatic effect of IDS 23, a stinging nettle leaf extract, on in vitro expression of T helper cytokines. J Rheumatol. 1999 Dec; 26(12): 2517-22.

Kraft, D. Long-term treatment of renal anaemia with mesterolone. Dtsch. Med. Wochenschr. 1980 Jun 6; 105(23): 830-2.

Landefeld, C.S. et al. Clomiphene-responsive hypogonadism in sickle cell anemia. Ann.
Intern. Med. 1983 Oct; 99(4): 480-3.

Loria, R.M. Antiglucocorticoid function of androstenetriol. Psychoneuroendocrinology 1997; 22(Suppl. 1): S103-S108.

Luo, X.S. Correlation between traditional Chinese medicine classification of 53 patients
with aplastic anemia and varieties of hemopoietic progenitor cells in vitro culture. Zhongguo Zhong Xi Yi Jie He Za Zhi 1992 Mar; 12(3): 139-41, 131.

Mantzioris, E. et al. Biochemical effects of a diet containing foods enriched with n-3 fatty acids. Am. J. Clin. Nutr. 2000 Jul; 72(1): 42-8.

Matsuda, M. et al. Clinical roles of vitamins in hematopoietic disorders. Nippon Rinsho 1999 Oct; 57(10): 2349-55.

McCann, M.E. et al. Effect of intravenous infusion of omega-3 and omega-6 lipid emulsions on equine monocyte fatty acid composition and inflammatory mediator
production in vitro. Shock 2000 Aug; 14(2): 222-8.

Mehta, A.B. et al. Haematological disorders in liver disease. Forum (Genova) 1998 Jan-Mar; 8(1): 8-25.

Obertreis, B. et al. Ex-vivo in-vitro inhibition of lipopolysaccharide stimulated tumor necrosis factor-alpha and interleukin-1 beta secretion in human whole blood by extractum Urticae dioicae foliorum. Arzneimittelforschung 1996 Apr; 46(4): 389-94.

Pavlatos, A.M. et al. Review of oxymetholone: a 17alpha-alkylated anabolic-androgenic steroid. Clin. Ther. 2001 Jun; 23(6): 789-801; discussion, 771.

Pentimone, F. et al. Clinical evaluation of anemia in the aged. Minerva Med. 1992 Jan-Feb; 83(1-2): 35-9.

Prasad, A.S. et al. Effect of zinc supplementation on serum testosterone level in adult
male sickle cell anemia subjects. Am. J. Hematol. 1981; 10(2): 119-27.

Radtke, H.W. et al. Serum erythropoietin concentration in anephric patients. Nephron
1978; 22(4-6): 361-5.

Reddi, K. et al. Interleukin 6 production by lipopolysaccharide-stimulated human
fibroblasts is potently inhibited by naphthoquinone (vitamin K) compounds. Cytokine 1995; Apr; 7(3): 287-90.

Reiter, Z., Ozes, O.N., Blatt, L.M., Taylor, M.W. Cytokine and natural killing regulation of growth of a hairy cell leukemia-like cell line: the role of interferon-alpha and interleukin-2. J. Immunother. 1992 Jan; 11(1): 40-9.

Remacha, A.F. et al. Serum erythropoietin and erythroid activity in vitamin B12 deficiency. Haematologica 1997 Jan-Feb; 82(1): 67-8.

Riehemann, K. et al. Plant extracts from stinging nettle (Urtica dioica), an antirheumatic remedy, inhibit the proinflammatory transcription. FEBS Lett. 1999; Jan 8; 442(1): 89-94.

Rodriguez, R.M. et al. Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J. Crit. Care 2001 Mar; 16(1): 36-41.

Somers, S.D. et al. Alteration of tumor necrosis factor-alpha production by macrophages from mice fed diets high in eicosapentaenoic and docosahexaenoic fatty acids. Cell Immunol. 1994 Feb; 153(2): 287-97.

Soyland, E. et al. Dietary supplementation with very long-chain n-3 fatty acids in man decreases expression of the interleukin-2 receptor (CD25) on mitogen-stimulated lymphocytes from patients with inflammatory skin diseases. Eur. J. Clin. Invest. 1994
Apr; 24(4): 236-42.

Straub, R.H. et al. Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. J. Clin. Endocrinol. Metab. 1998 Jun; 83(6): 2012-7.

Straub, R.H. et al. Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease. Am. J. Gastroenterol. 1998 Nov; 93(11): 2197-2202.

Straub, R.H. et al. Replacement therapy with DHEA plus corticosteroids in patients with chronic inflammatory diseases-substitutes of adrenal and sex hormones. Z. Rheumatol. 2000; 59(Suppl. 2): 108-18.

Teucher, T. et al. Cytokine secretion in whole blood of healthy subjects following oral administration of Urtica dioica L. plant extract. Arzneimittelforschung 1996 Sep; 46(9): 906-10.

Tomobe, Y.I. et al. Dietary docosahexaenoic acid suppresses inflammation and immunoresponses in contact hypersensitivity reaction in mice. Lipids 2000 Jan; 35(1): 61-9.

Yam, D. et al. Suppression of tumor growth and metastasis by dietary fish oil combined with vitamins E and C and cisplatin. Cancer Chemother. Pharmacol. 2001; 47(1): 34-40.

Zarazaga, A. et al. Folates in human nutrition. Different clinical situations in which folate deficiencies exist. Nutr. Hosp. 1991 Jul-Aug; 6(4): 207-26.




Related Articles Abstracts
Magazine
Magazine
Blueberry Extract

Home | Membership | Products | Magazine | Health Concerns | News | About Us | Legal Notices | Privacy Policy | Site Map

Products: Anti-Aging | Bone & Joint Support | Cardiovascular Health | Hormones | Mood, Stress & Well Being | Prostate Health | Vitamins | Weight Management
Health Concerns: Hormones (Female) | Hormones (Male) | Cholesterol | Arthritis | Blood Pressure | Diabetes | Osteoporosis | Prostate Cancer | Thyroid | Depression

All Contents Copyright © 1995-2008 Life Extension Foundation All rights reserved.

*These statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease. The information provided on this site is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional or any information contained on or in any product label or packaging. You should not use the information on this site for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. You should consult with a healthcare professional before starting any diet, exercise or supplementation program, before taking any medication, or if you have or suspect you might have a health problem. You should not stop taking any medication without first consulting your physician.